http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2555776-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77677d572bce2102f566161c5b39d2ee
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-32
filingDate 2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8856d4baad5990233616f511d3492c5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1444600653a5e7df183dc70048eca2f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7764de4d3abba57f6fa894a928f6ab27
publicationDate 2015-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2555776-C1
titleOfInvention Method of treating enthesitis and enthesopathies
abstract FIELD: medicine. n SUBSTANCE: involved enthesis is directly exposed to a therapeutic agent. It is injected with a common needle with having the bone tissue intact; the exposure to the Alloplant dispersed biomaterial dissolved in normal saline is also applied by administering it into the soft tissue depth above the whole surface of the enthesis. The therapeutic course involves 1-5 injections of the biomaterial in an amount of 5 ml every 8-12 days. Alloplant for injections is dissolved in a ratio of 50 mg of the biomaterial to 50 ml of normal saline. The number of procedures in the therapeutic courses and a procedure interval are specified individually depending on a degree of the enthesis involvement, as well as on the patient's weight and age. n EFFECT: method enables reducing inflammations of the enthesis and adjoining soft tissues and restoring the structure of the latter if degenerated, and increasing clinical effectiveness. n 3 cl, 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11680094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019099334-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2702867-C2
priorityDate 2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2493800-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727

Total number of triples: 22.